Dinutuximab treatment starts after high dose chemotherapy with autologous stem cell transplantation and continues for approximately six months. Part of the treatment can be administered at home.
All information about this treatment can be found in the brochure entitled Anti-GD2 immunotherapy.
The department enters your child’s treatment details in the brochure entitled Dinutuximab at home for you to take home.
Should you need any further information, please feel free to ask.